AE
DARE icon

AMH Equity’s Dare Bioscience DARE Stock Holding History

AMH Equity’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$488K Buy
232,373
+38,770
+20% +$87.4K 0.61% 44
2025
Q2 		$463K Buy
193,603
+29,301
+18% +$85.5K 0.61% 40
2025
Q1 		$475K Buy
164,302
+14,302
+10% +$44.4K 0.72% 39
2024
Q4 		$468K Buy
150,000
+50,000
+50% +$173K 0.46% 41
2024
Q3 		$324K Buy
100,000
+23,032
+30% +$78.7K 0.41% 41
2024
Q2 		$310K Buy
+76,968
New +$373K 0.41% 30

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

AMH Equity's DARE Position: Q3 2025 in Review

AMH Equity increased its Dare Bioscience (DARE) stake by 20% in Q3 2025, buying an estimated $87.4K and bringing the position to 232,373 shares worth $488K. The position accounts for 0.61% of the portfolio, ranked #44.

AMH Equity first reported a position in DARE in Q2 2024 and has held it in 6 quarters since. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2025.

  • AMH Equity held 232,373 shares of Dare Bioscience worth $488K as of Q3 2025.
  • AMH Equity bought 38,770 Dare Bioscience shares in Q3 2025, an estimated $87.4K.
  • Dare Bioscience made up 0.61% of AMH Equity's portfolio in Q3 2025, its #44 holding.
  • AMH Equity first reported a position in Dare Bioscience in Q2 2024 and has held it in 6 quarters since.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.